Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (−/−) mice and improved by combined administration of L‐arginine and antioxidants
Authors:
- 3 March 2008
- journal article
- Published by Wiley in Nephrology
- Vol. 13 (3) , 218-227
Abstract
SUMMARY: Aim Reduction in nitric oxide (NO) levels during kidney failure has been related to the reaction of NO with superoxide anions to yield peroxynitrite which possesses the biological activity responsible for renal damage. However, stimulation of the NO pathway ameliorates the progression of kidney failure. Thus, it is unclear whether NO prevents or acts as the compound responsible for the cytotoxicity observed during kidney failure.Methods We evaluated the development of kidney failure in animals that were wild type and deficient in endothelial NO synthase (eNOS (−/−)) and tested the effects of an antioxidant treatment and NO precursors on the generation of superoxide anion and kidney failure parameters.Results In wild‐type mice, five‐sixths nephrectomy increased proteinuria from 3.0 ± 0.35 to 14.5 ± 0.76 mg protein/24 h (P < 0.05), blood pressure from 83.1 ± 1.8 to 126.6 ± 1.7 mmHg (P < 0.05), and superoxide production from 1.4 ± 0.6% to 74.3 ± 0.8% (P < 0.05). The effects of five‐sixths nephrectomy on the eNOS (−/−) mice were greater compared with wild‐type mice. Proteinuria increased from 6.7 ± 0.5 to 22.7 ± 2.0 mg protein/24 h (P < 0.05), blood pressure increased from 93.3 ± 0.9 to 151.2 ± 3.4 mmHg (P < 0.05), and superoxide production increased from 12.9 ± 0.5% to 99.8 ± 1.3% (P < 0.05). The nitrotyrosine levels were lower in eNOS (−/−) mice as compared to wild‐type mice. A combination of L‐arginine and antioxidant treatment ameliorated renal damage. The effect was improved in wild‐type animals.Conclusion Our data support the relevance of NO as an antagonist to superoxide in renal tissues and suggest that the loss of this mechanism promotes the progression of kidney failure.Keywords
This publication has 31 references indexed in Scilit:
- Tempol Protects against Ischemic Acute Renal Failure by Inhibiting Renal Noradrenaline Overflow and Endothelin-1 OverproductionBiological and Pharmaceutical Bulletin, 2005
- Nitric oxide, oxidative stress, and progression of chronic renal failureSeminars in Nephrology, 2004
- Glomerular Oxidative and Antioxidative Systems in Experimental Mesangioproliferative GlomerulonephritisJournal of the American Society of Nephrology, 2002
- Plasma F2-isoprostane levels are elevated in chronic hemodialysis patientsClinical Nephrology, 2002
- Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxideKidney International, 2002
- Enhanced Nitric Oxide Inactivation and Protein Nitration by Reactive Oxygen Species in Renal InsufficiencyHypertension, 2002
- Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patientsCardiovascular Research, 2000
- Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the ratKidney International, 2000
- In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia.Journal of Clinical Investigation, 1996
- Oxygen free radicals in ischemic acute renal failure in the rat.Journal of Clinical Investigation, 1984